This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ardea Biosciences, Inc. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Chunrong Yu
Introduction
Chunrong Yu is a notable inventor based in Williamsville, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His work focuses on innovative combinations of inhibitors that target specific protein kinases.
Latest Patents
Chunrong Yu holds a patent for "Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof." This invention concerns combinations of inhibitors of MEK, Raf protein kinases, and other kinases including VEGFR1-3 and PDGFR-β. The patent also details pharmaceutical compositions comprising these compounds and methods of use, including applications in the treatment and prevention of cancer and other hyperproliferative disorders. He has 1 patent to his name.
Career Highlights
Chunrong Yu is currently employed at Ardea Biosciences, Inc., where he continues to advance his research and development efforts. His work has been instrumental in the exploration of new therapeutic avenues for cancer treatment.
Collaborations
Chunrong has collaborated with notable colleagues such as Jeffrey Miner and Mark Chapman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Chunrong Yu's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as an influential inventor. His innovative work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile